Crinetics Pharmaceuticals (CRNX) Prepaid Assets (2017 - 2026)
Crinetics Pharmaceuticals' (CRNX) quarterly Prepaid Assets came in at $6.4 million in Q1 2026, down 60.89% year-on-year from $16.4 million in Q1 2025, and down 63.98% quarter-over-quarter from $17.8 million in Q4 2025.
Crinetics Pharmaceuticals (CRNX) Prepaid Assets (2017 - 2026) Analysis & Trends
Crinetics Pharmaceuticals' Prepaid Assets history runs 10 years deep, the most recent figure standing at $6.4 million for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 60.89% year-over-year to $6.4 million in Q1 2026; TTM through Mar 2026 was $6.4 million, a 60.89% decrease from a year earlier, with the FY2025 full-year figure at $17.8 million, down 14.31% from the prior year.
- Prepaid Assets eased to $6.4 million in Q1 2026 per CRNX's latest filing, from $17.8 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $20.8 million in Q4 2024 and bottomed at $448000.0 in Q4 2023.
- The 5-year median for Prepaid Assets is $3.6 million (2024), against an average of $8.1 million.
- Across the five-year window, Prepaid Assets tumbled 92.73% in 2022 and surged 4547.1% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $1.9 million in 2022, then slumped by 76.79% to $448000.0 in 2023, then jumped by 4547.1% to $20.8 million in 2024, then dropped by 14.31% to $17.8 million in 2025, then sank by 63.98% to $6.4 million in 2026.
- Per Business Quant, the three latest CRNX Prepaid Assets figures stand at $6.4 million (Q1 2026), $17.8 million (Q4 2025), and $4.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Crinetics Pharmaceuticals | 8.71 Bn | 8.71 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.43 Mn |
| Dec 31, 2025 | 17.84 Mn |
| Sep 30, 2025 | 4.81 Mn |
| Jun 30, 2025 | 20.40 Mn |
| Mar 31, 2025 | 16.43 Mn |
| Dec 31, 2024 | 20.82 Mn |
| Sep 30, 2024 | 14.92 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 3.56 Mn |
| Dec 31, 2023 | 448,000.00 |
| Sep 30, 2023 | 3.52 Mn |
| Jun 30, 2023 | 20.28 Mn |
| Mar 31, 2023 | 583,000.00 |
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | 1.65 Mn |
| Jun 30, 2022 | 1.63 Mn |
| Mar 31, 2022 | 519,000.00 |
| Dec 31, 2021 | 888,000.00 |
| Sep 30, 2021 | 10.65 Mn |
| Jun 30, 2021 | 7.59 Mn |